Labcorp Holdings (LH) EBITDA (2009 - 2026)

Labcorp Holdings has disclosed EBITDA across 18 years of filings, most recently posting $380.8 million for Q1 2026.

• EBITDA for Q1 2026 came in at $380.8 million, up 16.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 31.89% YoY), and the FY2025 annual result was $1.4 billion, up 27.42% from the prior year.
• EBITDA came in at $380.8 million for Q1 2026 at Labcorp Holdings, up from $267.6 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $687.9 million in Q1 2022 to a low of -$122.8 million in Q4 2023.
• The 5-year median for EBITDA is $321.3 million (2024), against an average of $299.8 million.
• Across the five-year window, EBITDA slumped 530.88% in 2023 and surged 276.3% in 2024, its largest moves.
• Labcorp Holdings' EBITDA stood at $28.5 million in 2022, then plunged by 530.88% to -$122.8 million in 2023, then soared by 276.3% to $216.5 million in 2024, then rose by 23.6% to $267.6 million in 2025, then soared by 42.3% to $380.8 million in 2026.
• The last three EBITDA figures came in at $380.8 million (Q1 2026), $267.6 million (Q4 2025), and $396.6 million (Q3 2025), per Business Quant data.